Arezoo Astanehe
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
-
- Cancer-related molecular mechanisms research
Papers in
-
- RNA Research and Splicing 5
- Ubiquitin and proteasome pathways 3
- Oncology 11
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 3
- Co-authors
- Sandra E. Dunn (14 shared papers)Anna L. Stratford (7 shared papers)Kaiji Hu (6 shared papers)Abbas Fotovati (6 shared papers)Connie J. Eaves (4 shared papers)Karen To (5 shared papers)Isabelle M. Berquin (3 shared papers)Ashleen Shadeo (3 shared papers)
- Journals
- Oncogene (4 papers)Cancer Research (3 papers)Journal of Cell Science (2 papers)PLoS ONE (2 papers)Melanoma Research (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Arezoo Astanehe
18 papers receiving 903 citations
Peers
Comparison fields: 5 of 70
- Oncology 242
- Cancer Research 118
- Molecular Biology 573
- Immunology and Allergy 26
- Pathology and Forensic Medicine 62
Countries citing papers authored by Arezoo Astanehe
This map shows the geographic impact of Arezoo Astanehe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arezoo Astanehe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arezoo Astanehe more than expected).
Fields of papers citing papers by Arezoo Astanehe
This network shows the impact of papers produced by Arezoo Astanehe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arezoo Astanehe. The network helps show where Arezoo Astanehe may publish in the future.
Co-authors
The 25 scholars most cited alongside Arezoo Astanehe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 145 | |
| 2 | 2007 | 122 | |
| 3 | 2008 | 97 | |
| 4 | 2009 | 81 | |
| 5 | 2018 | 79 | |
| 6 | 2008 | 66 | |
| 7 | 2009 | 64 | |
| 8 | 2012 | 47 | |
| 9 | YB-1 is a Transcription/Translation Factor that Orchestrates the Oncogenome by Hardwiring Signal Transduction to Gene Expression. | 2007 | 45 |
| 10 | 2010 | 44 | |
| 11 | 2010 | 43 | |
| 12 | 2014 | 36 | |
| 13 | 2013 | 20 | |
| 14 | 2014 | 13 | |
| 15 | 2017 | 8 | |
| 16 | 2013 | 2 | |
| 17 | 2008 | 1 | |
| 18 | 2020 | 1 |
About Arezoo Astanehe
Arezoo Astanehe is a scholar working on Molecular Biology, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 18 papers that have together received 914 indexed citations. Recurring topics across this work include RNA Research and Splicing (5 papers), Cancer-related Molecular Pathways (4 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Cells and Metastasis (3 papers), HER2/EGFR in Cancer Research (3 papers), Enhanced Recovery After Surgery (2 papers), Microtubule and mitosis dynamics (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Oncology (242 citations), Cancer Research (118 citations), Molecular Biology (573 citations), Immunology and Allergy (26 citations) and Pathology and Forensic Medicine (62 citations). Arezoo Astanehe has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Sandra E. Dunn, Anna L. Stratford, Kaiji Hu, Abbas Fotovati, Connie J. Eaves, Karen To, Isabelle M. Berquin, Ashleen Shadeo, Alastair Davies and Gordon B. Mills. Their work appears in journals such as Oncogene, Cancer Research, Journal of Cell Science, PLoS ONE and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.